UBS Reiterates Neutral Rating on Gentex Corporation (GNTX)

Market Context

Gentex Corporation operates in the Consumer Cyclical sector. The stock currently trades at $20.64 with a market capitalization of $5.2B. The stock has declined 12.7% over the past 52 weeks.

Analyst coverage from UBS provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Gentex Corporation.

Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.

Recent Analyst Activity for Gentex Corporation

Among the 10 most recent ratings: 1 Buy, 8 Hold, 1 Sell.

Date	Firm	Rating	Price Target
Oct 26, 2026	JP Morgan	Neutral	N/A
Oct 26, 2026	BNP Paribas	Neutral	N/A
Oct 26, 2026	UBS	Neutral	N/A
Oct 26, 2026	B. Riley Securities	Buy	N/A
Oct 26, 2026	Baird	Neutral	N/A

Related Tools: Analyst Ratings Dashboard | View GNTX Stock Page